Framingham: Inflammation, Genes & Cardiovascular Disease

CompletedOBSERVATIONAL
Enrollment

7,374

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
AtherosclerosisCardiovascular DiseasesHeart DiseasesInflammation
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Boston University

OTHER

NCT00083863 - Framingham: Inflammation, Genes & Cardiovascular Disease | Biotech Hunter | Biotech Hunter